Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.

SAN DIEGO, July 19, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced its participation in the fifth annual Glioblastoma Awareness Day, July 19, 2023 in Washington, D.C. Originally introduced to the Senate by a bipartisan group of U.S. senators, the inaugural Glioblastoma Awareness Day took place on July 17, 2019. 

Read more at prnewswire.com